Drug Shortage Report for NIDAGEL
Report ID | 174138 |
Drug Identification Number | 02125226 |
Brand name | NIDAGEL |
Common or Proper name | NIDAGEL |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | METRONIDAZOLE |
Strength(s) | 0.75% |
Dosage form(s) | GEL |
Route of administration | VAGINAL VAGINAL |
Packaging size | 70g |
ATC code | G01AF |
ATC description | ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST. |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2022-11-21 |
Actual start date | 2022-11-04 |
Estimated end date | 2023-01-26 |
Actual end date | 2023-01-23 |
Shortage status | Resolved |
Updated date | 2023-01-25 |
Company comments | Capacity Problem in Production |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-11-09 | English | Compare |
v2 | 2022-11-09 | French | Compare |
v3 | 2022-11-17 | English | Compare |
v4 | 2022-11-17 | French | Compare |
v5 | 2022-12-21 | English | Compare |
v6 | 2022-12-21 | French | Compare |
v7 | 2023-01-11 | English | Compare |
v8 | 2023-01-11 | French | Compare |
v9 | 2023-01-25 | English | Compare |
v10 | 2023-01-25 | French | Compare |
Showing 1 to 10 of 10